麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

泰格醫(yī)藥, Tigermed ,   
杭州泰格醫(yī)藥科技股份有限公司是國內(nèi)領(lǐng)先的臨床合同研究組織（CRO），專注于為醫(yī)藥產(chǎn)品研發(fā)提供I-IV期臨床試驗(yàn)、數(shù)據(jù)管理與生物統(tǒng)計(jì)、注冊(cè)申報(bào)等全方位服務(wù)。公司自成立以來，一直致力于為客戶提供高質(zhì)量和高效率的醫(yī)藥研發(fā)服務(wù)，幫助客戶降低研發(fā)風(fēng)險(xiǎn)、節(jié)約研發(fā)經(jīng)費(fèi)，推進(jìn)產(chǎn)品市場化進(jìn)程。

公司總部位于杭州，下設(shè)七家子公司，構(gòu)筑了涵蓋臨床研究產(chǎn)業(yè)鏈各個(gè)環(huán)節(jié)的完整服務(wù)體系。截止2011年底，在國內(nèi)40多個(gè)主要城市設(shè)有辦事機(jī)構(gòu)，擁有近600人的國際化專業(yè)團(tuán)隊(duì)，建立了國際標(biāo)準(zhǔn)的操作規(guī)程（SOP）。泰格醫(yī)藥已經(jīng)為國內(nèi)外300多家客戶成功提供了近千項(xiàng)臨床試驗(yàn)、注冊(cè)申報(bào)、數(shù)據(jù)管理和生物統(tǒng)計(jì)服務(wù)。因?yàn)閾碛?3種創(chuàng)新藥（包括23種新化學(xué)單體和10個(gè)新生物制品）的臨床研究經(jīng)驗(yàn)與成就，泰格醫(yī)藥是國內(nèi)領(lǐng)先的“創(chuàng)新型CRO”。

Hangzhou Tigermed Consulting Co., Ltd is a leading Contract Research Organization (CRO) in China dedicated to providing regulatory affairs, Phase I-IV clinical trials, data management, biostatistics, medical translation and GCP training services for healthcare products. Since inception in 2004, Tigermed has been committed to accelerating your product development timeline while reducing R&D costs and risks, helping you to bring the miracles of your new product to market effectively.

Headquartered in Hangzhou, Tigermed operates 7 subsidiaries, 40 offices in China mainland. With more than 600 staff, Tigermed has set up global Standard Operating Procedures (SOPs) and successfully serviced more than 300 local and global clients in the conduct of hundreds of regulatory affairs, clinical trials, data management and biostatistics projects. Through our unmatched experience and outstanding achievements in the development of 33 innovative drugs (23 NCEs and 10 new biological products), Tigermed is recognized as “An Innovative CRO” in China.